Glucose-6-phosphate dehydrogenase-beyond the realm of red cell biology

Free Radical Research

Volumn 48, Issue 9, 2014, Pages 1028-1048

  Ho, H Y ^a   Cheng, M L ^a,b   Chiu, D T Y ^a,b,c  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Antioxidant; G6PD; NADPH; Reactive oxygen species

Indexed keywords

GLUCOSE 6 PHOSPHATE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

CANCER SUSCEPTIBILITY; CARDIOVASCULAR DISEASE; CELL GROWTH; CONFERENCE PAPER; DEGENERATIVE DISEASE; DIABETES MELLITUS; EMBRYO DEVELOPMENT; ERYTHROCYTE; FAVISM; GENETIC VARIABILITY; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEMOLYTIC ANEMIA; HOMEOSTASIS; HUMAN; INFECTION SENSITIVITY; NEWBORN JAUNDICE; NONHUMAN; OXIDATION REDUCTION STATE; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; GENETICS; PHYSIOLOGY;

GLUCOSEPHOSPHATE DEHYDROGENASE; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HUMANS;

EID: 84906070209     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2014.913788     Document Type: Conference Paper

References (225)

1. Luzzatto L, Battistuzzi G. Glucose-6-phosphate dehydrogenase . Adv Hum Genet 1985 14 217-329, 386-388
2. Scott MD, Zuo L, Lubin BH, Chiu DT. NADPH, not glutathione, status modulates oxidant sensitivity in normal and glucose-6-phosphate dehydrogenase-defi cient erythrocytes. Blood 1991 77 2059-2064
3. Beutler E. The genetics of glucose-6-phosphate dehydrogenase defi ciency. Semin Hematol 1990 27 137-164
4. Beutler E. Glucose-6-phosphate dehydrogenase defi ciency. N Engl J Med 1991; 324: 169-174
5. WHO Working Group. Glucose-6-phosphate dehydrogenase defi ciency. WHO Working Group. Bull World Health Organ 1989 67 601-611
6. Standardization of procedures for the study of glucose-6-phosphate dehydrogenase. Report of a WHO Scientifi c Group. World Health Organ Tech Rep Ser 1967 366 1-53
7. Beutler E. Glucose-6-phosphate dehydrogenase defi ciency and red cell glutathione peroxidase. Blood 1977; 49: 467-469
8. Allison AC. Glucose-6-phosphate dehydrogenase defi ciency in red blood cells of East Africans. Nature 1960 186 531-532
9. Adam A. Linkage between Defi ciency of glucose-6-phosphate dehydrogenase and colour-blindness. Nature 1961 189 686
10. Boyer SH, Porter IH, Weilbacher RG. Electrophoretic heterogeneity of glucose-6-phosphate dehydrogenase and its relationship to enzyme defi ciency in man. Proc Natl Acad Sci U S A 1962 48 1868-1876
11. Persico MG, Viglietto G, Martini G, Toniolo D, Paonessa G, Moscatelli C, et al. Isolation of human glucose-6-phosphate dehydrogenase (G6PD) cDNA clones: Primary structure of the protein and unusual 5 'non-coding region. Nucleic Acids Res 1986 14 2511-2522
12. Martini G, Toniolo D, Vulliamy T, Luzzatto L, Dono R, Viglietto G, et al. Structural analysis of the X-linked gene encoding human glucose 6-phosphate dehydrogenase. Embo J 1986 5 1849-1855
13. Toniolo D, Persico MG, Battistuzzi G, Luzzatto L. Partial purifi cation and characterization of the messenger RNA for human glucose-6-phosphate dehydrogenase. Mol Biol Med 1984 2 89-103
14. Takizawa T, Huang IY, Ikuta T, Yoshida A. Human glucose-6-phosphate dehydrogenase: Primary structure and cDNA cloning. Proc Natl Acad Sci U S A 1986 83 4157-4161
15. Hirono A, Beutler E. Molecular cloning and nucleotide sequence of cDNA for human glucose-6-phosphate dehydrogenase variant A(-). Proc Natl Acad Sci U S A 1988 85 3951-3954
16. Beutler E, Vulliamy TJ. Hematologically important mutations: Glucose-6-phosphate dehydrogenase. Blood Cells Mol Dis 2002 28 93-103
17. Vulliamy TJ, D 'Urso M, Battistuzzi G, Estrada M, Foulkes NS, Martini G, et al. Diverse point mutations in the human glucose-6-phosphate dehydrogenase gene cause enzyme defi ciency and mild or severe hemolytic anemia. Proc Natl Acad Sci U S A 1988 85 5171-5175
18. Arese P, De Flora A. Pathophysiology of hemolysis in glucose-6-phosphate dehydrogenase defi ciency. Semin Hematol 1990 27 1-40
19. Beutler E. G6PD defi ciency. Blood 1994 84 3613-3636
20. Beutler E. Glucose-6-phosphate dehydrogenase defi ciency: A historical perspective. Blood 2008 111 16-24
21. Du SD. Favism in west China. Chin Med J 1952 70 17-26
22. Du CS, Xu YK, Hua XY, Wu QL, Liu LB. Glucose-6-phosphate dehydrogenase variants and their frequency in Guangdong, China. Hum Genet 1988 80 385-388
23. Du CS, Liu LB, Liu B, Tokunaga K, Omoto K. Glucose-6-phosphate dehydrogenase defi ciency among three national minorities in Hainan Island, China. Gene Geogr 1988 2 71-74
24. Lai HC, Lai MP, Leung KS. Glucose-6-phosphate dehydrogenase defi ciency in Chinese. J Clin Pathol 1968 21 44-47
25. Chan TK, Todd D, Wong CC. Erythrocyte glucose-6-phosphate dehydrogenase defi ciency in chinese. Br Med J 1964 2 102
26. Yue PC, Strickland M. Glucose-6-phosphate-dehydrogenase defi ciency and neonatal jaundice in Chinese male infants in Hong Kong. Lancet 1965 285 350-351
27. Chen SH, Chen CL. [Clinical observation of kernicterus in Chinese newborns.]. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 1963 4 39-44
28. Chen HC. Kernicterus in the Chinese newborn. A morphological and spectrophotometric study J Neuropathol Exp Neurol 1964 23 527-549
29. Lin TM, Lin KS, Song ST, Su HY. A study of an outbreak of acute hemolytic anemia possibly caused by fava beans. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 1961 2 99-105
30. McCurdy PR, Kirkman HN, Naiman JL, Jim RT, Pickard BM. A Chinese variant of glucose-6-phosphate dehydrogenase. J Lab Clin Med 1966 67 374-385
31. McCurdy PR, Blackwell RQ, Todd D, Tso SC, Tuchinda S. Further studies on glucose-6-phosphate dehydrogenase defi ciency in Chinese subjects. J Lab Clin Med 1970 75 788-797
32. Howes RE, Piel FB, Patil AP, Nyangiri OA, Gething PW, Dewi M, et al. G6PD defi ciency prevalence and estimates of aff ected populations in malaria endemic countries: A geostatistical model-based map. PLoS Med 2012 9 e1001339
33. Nkhoma ET, Poole C, Vannappagari V, Hall SA, Beutler E. The global prevalence of glucose-6-phosphate dehydrogenase defi ciency: A systematic review and meta-Analysis. Blood Cells Mol Dis 2009 42 267-278
34. Ho HY, Daniel DTY. Molecular diagnosis of G6PD defi -ciency. In: Wu JJ, (ed.). Textbook of Molecular Diagnosis in Medicine. Taipei: Wu Nan Book Inc.; 2009. pp. 183-212
35. Chien YH, Lee NC, Wu ST, Liou JJ, Chen HC, Hwu WL. Changes in incidence and sex ratio of glucose-6-phosphate dehydrogenase defi ciency by population Drift in Taiwan. Southeast Asian J Trop Med Public Health 2008 39 154-161
36. Chiang SH, Wu SJ, Wu KF, Hsiao KJ. Neonatal screening for glucose-6-phosphate dehydrogenase defi ciency in Taiwan. Southeast Asian J Trop Med Public Health 1999 30 72-74
37. Hsiao KJ. Genetic disorders and neonatal screening. In: Miyai K, Kanno T, Ishikawa E, (eds.). Clinical Biochemistry. Amsterdam: Elsevier 1992. pp. 289-292
38. Cheng HY, Fu YJ, Lee CB, Lo SK, Hung CM, Chiu DTY. Incidence of glucose-6-phosphate dehydrogenase defi ciency in blood donors of Taiwan. J Biomed Lab Sci 1994 6 43-48
39. Kaplan M, Hammerman C. Neonatal screening for glucose-6-phosphate dehydrogenase defi ciency: Biochemical versus genetic technologies. Semin Perinatol 2011 35 155-161
40. Stevens DJ, Wanachiwanawin W, Mason PJ, Vulliamy TJ, Luzzatto L. G6PD Canton a common Defi cient variant in South East Asia caused by a 459 Arg-Leu mutation. Nucleic Acids Res 1990 18 7190
41. Vulliamy TJ, Kaeda JS, Ait-Chafa D, Mangerini R, Roper D, Barbot J, et al. Clinical and haematological consequences of recurrent G6PD mutations and a single new mutation causing chronic nonspherocytic haemolytic anaemia. Br J Haematol 1998; 101: 670-675
42. Vulliamy T, Luzzatto L, Hirono A, Beutler E. Hematologically important mutations: Glucose-6-phosphate dehydrogenase . Blood Cells Mol Dis 1997 23 302-313
43. Chen EY, Cheng A, Lee A, Kuang WJ, Hillier L, Green P, et al. Sequence of human glucose-6-phosphate dehydrogenase cloned in plasmids and a yeast artifi cial chromosome. Genomics 1991 10 792-800
44. Kanno H, Kondoh T, Yoshida A. 5 'structure and expression of human glucose-6-phosphate dehydrogenase mRNA. DNA Cell Biol 1993 12 209-215
45. Franze A, Ferrante MI, Fusco F, Santoro A, Sanzari E, Martini G, Ursini MV. Molecular anatomy of the human glucose 6-phosphate dehydrogenase core promoter. FEBS Lett 1998 437 313-318
46. Toniolo D, Filippi M, Dono R, Lettieri T, Martini G. The CpG island in the 5 'region of the G6PD gene of man and mouse. Gene 1991 102 197-203
47. Trask BJ, Massa H, Kenwrick S, Gitschier J. Mapping of human chromosome Xq28 by two-color fl uorescence in situ hybridization of DNA sequences to interphase cell nuclei. Am J Hum Genet 1991 48 1-15
48. Jin DY, Jeang KT. Isolation of full-length cDNA and chromosomal localization of human NF-kappaB modulator NEMO to Xq28. J Biomed Sci 1999 6 115-120
49. Galgoczy P, Rosenthal A, Platzer M. Human-mouse comparative sequence analysis of the NEMO gene reveals an alternative promoter within the neighboring G6PD gene. Gene 2001 271 93-98
50. Minucci A, Moradkhani K, Hwang MJ, Zuppi C, Giardina B, Capoluongo E. Glucose-6-phosphate dehydrogenase (G6PD) mutations database: Review of the " old " and update of the new mutations. Blood Cells Mol Dis 2012 48 154-165
51. Mazieres S, Petit F, Dugoujon JM, Iriart X, Berry A, Carme B, et al. Subtle adjustments of the glucose-6-phosphate dehydrogenase (G6PD) mutation Database and reference sequence. Blood Cells Mol Dis 2014 52 55-56
52. Hirono A, Fujii H, Shima M, Miwa S. G6PD Nara: A new class 1 glucose-6-phosphate dehydrogenase variant with an eight amino acid deletion. Blood 1993 82 3250-3252
53. Manco L, Pereira J, Relvas L, Rebelo U, Crisostomo AI, Bento C, Ribeiro ML. Chronic hemolytic anemia is associated with a new glucose-6-phosphate dehydrogenase in-frame deletion in an older woman. Blood Cells Mol Dis 2011 46 288-293
54. Longo L, Vanegas OC, Patel M, Rosti V, Li H, Waka J, et al. Maternally transmitted severe glucose 6-phosphate dehydrogenase defi ciency is an embryonic lethal. Embo J 2002 21 4229-4239
55. Xu W, Westwood B, Bartsocas CS, Malcorra-Azpiazu JJ, Indrak K, Beutler E. Glucose-6 phosphate dehydrogenase mutations and haplotypes in various ethnic groups. Blood 1995 85 257-263
56. Eff erth T, Bachli EB, Schwarzl SM, Goede JS, West C, Smith JC, Beutler E. Glucose-6-phosphate dehydrogenase (G6PD) defi ciency-Type Zurich: A splice site mutation as an uncommon mechanism producing enzyme defi ciency. Blood 2004 104 2608
57. Cheng YS, Tang TK, Hwang M. Amino acid conservation and clinical severity of human glucose-6-phosphate dehydrogenase mutations. J Biomed Sci 1999 6 106-114
58. Notaro R, Afolayan A, Luzzatto L. Human mutations in glucose 6-phosphate dehydrogenase refl ect evolutionary history. FASEB J 2000; 14: 485-494
59. Kotaka M, Gover S, Vandeputte-Rutten L, Au SW, Lam VM, Adams MJ. Structural studies of glucose-6-phosphate and NADP binding to human glucose-6-phosphate dehydrogenase. Acta Crystallogr D Biol Crystallogr 2005 61 495-504
60. Rowland P, Basak AK, Gover S, Levy HR, Adams MJ. The three-dimensional structure of glucose 6-phosphate dehydrogenase from Leuconostoc mesenteroides refi ned at 2.0 A resolution. Structure 1994; 2: 1073-1087
61. Au SW, Gover S, Lam VM, Adams MJ. Human glucose-6-phosphate dehydrogenase: The crystal structure reveals a structural NADP(- ) molecule and provides insights into enzyme defi ciency. Structure 2000; 8: 293-303
62. Wang XT, Chan TF, Lam VM, Engel PC. What is the role of the second " structural" NADP- -binding site in human glucose 6-phosphate dehydrogenase?. Protein Sci 2008; 17: 1403-1411
63. Roos D, van Zwieten R, Wijnen JT, Gomez-Gallego F, de Boer M, Stevens D, et al. Molecular basis and enzymatic properties of glucose 6-phosphate dehydrogenase volendam, leading to chronic nonspherocytic anemia, granulocyte dysfunction, and increased susceptibility to infections. Blood 1999 94 2955-2962
64. Gomez-Gallego F, Garrido-Pertierra A, Bautista JM. Structural defects underlying protein Dysfunction in human glucose-6-phosphate dehydrogenase A(-) defi ciency. J Biol Chem 2000 275 9256-9262
65. Hirono A, Kawate K, Honda A, Fujii H, Miwa S. A single mutation 202G- A in the human glucose-6-phosphate dehydrogenase gene (G6PD) can cause acute hemolysis by itself. Blood 2002 99 1498
66. Abdel Fattah M, Abdel Ghany E, Adel A, Mosallam D, Kamal S. Glucose-6-phosphate dehydrogenase and red cell pyruvate kinase defi ciency in neonatal jaundice cases in Egypt. Pediatr Hematol Oncol 2010; 27: 262-271
67. Ronquist G, Theodorsson E. Inherited, non-spherocytic haemolysis due to defi ciency of glucose-6-phosphate dehydrogenase . Scand J Clin Lab Invest 2007 67 105-111
68. Lee DH, Warkentin TE, Neame PB, Ali MA. Acute hemolytic anemia precipitated by myocardial infarction and pericardial tamponade in G6PD defi ciency. Am J Hematol 1996 51 174-175
69. Kaplan M, Hammerman C. Glucose-6-phosphate dehydrogenase defi ciency and severe neonatal hyperbilirubinemia: A complexity of interactions between genes and environment. Semin Fetal Neonatal Med 2010; 15: 148-156
70. Kaplan M, Renbaum P, Levy-Lahad E, Hammerman C, Lahad A, Beutler E. Gilbert syndrome and glucose-6-phosphate dehydrogenase defi ciency: A dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia. Proc Natl Acad Sci U S A 1997 94 12128-12132
71. Kaplan M. Gilbert 's syndrome and jaundice in glucose-6-phosphate dehydrogenase defi cient neonates. Haematologica 2000 85 E01
72. Kaplan M, Hammerman C. Glucose-6-phosphate dehydrogenase defi ciency: A potential source of severe neonatal hyperbilirubinaemia and kernicterus. Semin Neonatol 2002 7 121-128
73. Kaplan M, Hammerman C. Glucose-6-phosphate dehydrogenase defi ciency: A hidden risk for kernicterus. Semin Perinatol 2004; 28: 356-364
74. Beutler E, Duparc S, G6PD Defi ciency Working Group. Glucose-6-phosphate dehydrogenase defi ciency and antimalarial drug development. Am J Trop Med Hyg 2007 77 779-789
75. Youngster I, Arcavi L, Schechmaster R, Akayzen Y, Popliski H, Shimonov J, et al. Medications and glucose-6-phosphate dehydrogenase defi ciency: An evidence-based review. Drug Saf 2010; 33: 713-726
76. Rochford R, Ohrt C, Baresel PC, Campo B, Sampath A, Magill AJ, et al. Humanized mouse model of glucose 6-phosphate dehydrogenase defi ciency for in vivo assessment of hemolytic toxicity. Proc Natl Acad Sci U S A 2013 110 17486-17491
77. Yang Y, Li Z, Nan P, Zhang X. Drug-induced glucose-6-phosphate dehydrogenase defi ciency-related hemolysis risk assessment. Comput Biol Chem 2011; 35: 189-192
78. Siddiqui T, Khan AH. Hepatitis A and cytomegalovirus infection precipitating acute hemolysis in glucose-6-phosphate dehydrogenase defi ciency. Mil Med 1998 163 434-435
79. Au WY, Ngai CW, Chan WM, Leung RY, Chan SC. Hemolysis and methemoglobinemia due to hepatitis E virus infection in patient with G6PD defi ciency. Ann Hematol 2011 90 1237-1238
80. Thapa R, Pramanik S, Biswas B, Mallick D. Hepatitis E virus infection in a 7-year-old boy with glucose 6-phosphate dehydrogenase defi ciency. J Pediatr Hematol Oncol 2009 31 223-224
81. Schuurman M, van Waardenburg D, Da Costa J, Niemarkt H, Leroy P. Severe hemolysis and methemoglobinemia following fava beans ingestion in glucose-6-phosphatase dehydrogenase defi ciency: Case report and literature review. Eur J Pediatr 2009 168 779-782
82. Matthay KK, Mentzer WC. Erythrocyte enzymopathies in the newborn. Clin Haematol 1981 10 31-55
83. Kaplan M, Hammerman C, Vreman HJ, Stevenson DK, Beutler E. Acute hemolysis and severe neonatal hyperbilirubinemia in glucose-6-phosphate dehydrogenase-defi cient heterozygotes. J Pediatr 2001 139 137-140
84. Sgro M, Campbell D, Shah V. Incidence and causes of severe neonatal hyperbilirubinemia in Canada. CMAJ 2006 175 587-590
85. Watchko JF, Lin Z. Exploring the genetic architecture of neonatal hyperbilirubinemia. Semin Fetal Neonatal Med 2010 15 169-175
86. Kaplan M, Vreman HJ, Hammerman C, Leiter C, Abramov A, Stevenson DK. Contribution of haemolysis to jaundice in Sephardic Jewish glucose-6-phosphate dehydrogenase defi -cient neonates. Br J Haematol 1996 93 822-827
87. Seidman DS, Shiloh M, Stevenson DK, Vreman HJ, Gale R. Role of hemolysis in neonatal jaundice associated with glucose-6 phosphate dehydrogenase defi ciency. J Pediatr 1995 127 804-806
88. Winterbourn CC. Inhibition of autoxidation of divicine and isouramil by the combination of superoxide dismutase and reduced glutathione. Arch Biochem Biophys 1989; 271: 447-455
89. Winterbourn CC, Cowden WB, Sutton HC. Auto-oxidation of dialuric acid, divicine and isouramil. Superoxide dependent and independent mechanisms. Biochem Pharmacol 1989 38 611-618
90. Fischer TM, Meloni T, Pescarmona GP, Arese P. Membrane cross bonding in red cells in favic crisis: A missing link in the mechanism of extravascular haemolysis. Br J Haematol 1985 59 159-169
91. Arese P, Gallo V, Pantaleo A, Turrini F. Life and death of glucose-6-phosphate dehydrogenase (G6PD) defi cient erythrocytes - role of redox stress and band 3 modifi cations. Transfus Med Hemother 2012 39 328-334
92. Walsh SB, Stewart GW. Anion exchanger 1: Protean function and associations. Int J Biochem Cell Biol 2010 42 1919-1922
93. Ferru E, Giger K, Pantaleo A, Campanella E, Grey J, Ritchie K, et al. Regulation of membrane-cytoskeletal inter actions by tyrosine phosphorylation of erythrocyte band 3. Blood 2011 117 5998-6006.
94. Pantaleo A, Ferru E, Carta F, Mannu F, Simula LF, Khadjavi A, et al. Irreversible AE1 tyrosine phosphorylation leads to membrane vesiculation in G6PD defi cient red cells. PLoS One 2011 6 e15847
95. Pantaleo A, De Franceschi L, Ferru E, Vono R, Turrini F. Current knowledge about the functional roles of phosphorylative changes of membrane proteins in normal and diseased red cells. J Proteomics 2010 73 445-455
96. Turrini F, Arese P, Yuan J, Low PS. Clustering of integral membrane proteins of the human erythrocyte membrane stimulates autologous IgG binding, complement deposition, and phagocytosis. J Biol Chem 1991 266 23611-23617
97. Pantaleo A, Ferru E, Giribaldi G, Mannu F, Carta F, Matte A, et al. Oxidized and poorly glycosylated band 3 is selectively phosphorylated by Syk kinase to form large membrane clusters in normal and G6PD-defi cient red blood cells. Biochem J 2009 418 359-367
98. Arese P, Turrini F, Schwarzer E. Band 3/complementmediated recognition and removal of normally senescent and pathological human erythrocytes. Cell Physiol Biochem 2005 16 133-146
99. Tian WN, Braunstein LD, Pang J, Stuhlmeier KM, Xi QC, Tian X, Stanton RC. Importance of glucose-6-phosphate dehydrogenase activity for cell growth. J Biol Chem 1998 273 10609-10617
100. Koh WS, Choi WH, Lee SJ, Park C, Park CH. Enhancement of plasmacytoma cell growth by ascorbic acid is mediated via glucose 6-phosphate dehydrogenase. Cancer Res Treat 2007 39 22-29
101. Raineri R, Levy HR. On the specifi city of steroid interaction with mammary glucose 6-phosphate dehydrogenase. Biochemistry 1970 9 2233-2243
102. Oertel GW, Benes P. The eff ects of steroids on glucose-6-phosphate dehydrogenase. J Steroid Biochem 1972 3 493-496
103. Oertel GW, Rebelein I. Eff ects of dehydroepiandrosterone and its conjugates upon the activity of glucose-6-phosphate dehydrogenase in human erythrocytes. Biochim Biophys Acta 1969 184 459-460
104. Cheng ML, Shiao MS, Chiu DT, Weng SF, Tang HY, Ho HY. Biochemical disorders associated with antiproliferative eff ect of dehydroepiandrosterone in hepatoma cells as revealed by LC-based metabolomics. Biochem Pharmacol 2011 82 1549-1561
105. Ho HY, Cheng ML, Chiu HY, Weng SF, Chiu DT. Dehydroepiandrosterone induces growth arrest of hepatoma cells via alteration of mitochondrial gene expression and function. Int J Oncol 2008 33 969-977
106. Ho HY, Cheng ML, Lu FJ, Chou YH, Stern A, Liang CM, Chiu DT. Enhanced oxidative stress and accelerated cellular senescence in glucose-6-phosphate dehydrogenase (G6PD)-defi cient human fi broblasts. Free Radic Biol Med 2000 29 156-169
107. Cheng ML, Ho HY, Wu YH, Chiu DT. Glucose-6-phosphate dehydrogenase-defi cient cells show an increased propensity for oxidant-induced senescence. Free Radic Biol Med 2004 36 580-591
108. Johnson FB, Sinclair DA, Guarente L. Molecular biology of aging. Cell 1999 96 291-302
109. Beckman KB, Ames BN. Oxidants, antioxidants and aging. In: Scandalios JG, (ed.). Oxidative stress, and the Molecular Biology of Antioxidant Defenses. New York: Cold Spring Harbour Laboratory Press; 1997. pp. 201-272
110. Cheng ML, Ho HY, Liang CM, Chou YH, Stern A, Lu FJ, Chiu DT. Cellular glucose-6-phosphate dehydrogenase (G6PD) status modulates the eff ects of nitric oxide (NO) on human foreskin fi broblasts. FEBS Lett 2000 475 257-262
111. Ho HY, Wei TT, Cheng ML, Chiu DT. Green tea polyphenol epigallocatechin-3-gallate protects cells against peroxynitrite-induced cytotoxicity: Modulatory eff ect of cellular G6PD status. J Agric Food Chem 2006; 54: 1638-1645
112. Gao LP, Cheng ML, Chou HJ, Yang YH, Ho HY, Chiu DT. Ineff ective GSH regeneration enhances G6PD-knockdown Hep G2 cell sensitivity to diamide-induced oxidative damage. Free Radic Biol Med 2009; 47: 529-535
113. Pandolfi PP, Sonati F, Rivi R, Mason P, Grosveld F, Luzzatto L. Targeted disruption of the housekeeping gene encoding glucose 6-phosphate dehydrogenase (G6PD): G6PD is dispensable for pentose synthesis but essential for defense against oxidative stress. Embo J 1995 14 5209-5215
114. Zhang W, Ni C, Sheng J, Hua Y, Ma J, Wang L, et al. TLQP-21 protects human umbilical vein endothelial cells against high-glucose-induced apoptosis by increasing G6PD expression. PLoS One 2013 8 e79760
115. Davies KJ. The broad spectrum of responses to oxidants in proliferating cells: A new paradigm for oxidative stress. IUBMB Life 1999 48 41-47
116. Marinho HS, Real C, Cyrne L, Soares H, Antunes F. Hydrogen peroxide sensing, signaling and regulation of transcription factors. Redox Biol 2014; 2: 535-562
117. Wiese AG, Pacifi ci RE, Davies KJ. Transient adaptation of oxidative stress in mammalian cells. Arch Biochem Biophys 1995 318 231-240
118. Leopold JA, Walker J, Scribner AW, Voetsch B, Zhang YY, Loscalzo AJ, et al. Glucose-6-phosphate dehydrogenase modulates vascular endothelial growth factor-mediated angiogenesis. J Biol Chem 2003 278 32100-32106
119. Leopold JA, Zhang YY, Scribner AW, Stanton RC, Loscalzo J. Glucose-6-phosphate dehydrogenase overexpression Decreases endothelial cell oxidant stress and increases bioavailable nitric oxide. Arterioscler Thromb Vasc Biol 2003 23 411-417
120. Ham M, Lee JW, Choi AH, Jang H, Choi G, Park J, et al. Macrophage glucose-6-phosphate dehydrogenase stimulates proinfl ammatory responses with oxidative stress. Mol Cell Biol 2013 33 2425-2435
121. Yang HC, Cheng ML, Ho HY, Chiu DT. The microbicidal and cytoregulatory roles of NADPH oxidases. Microbes Infect 2011 13 109-120
122. Forman HJ, Torres M. Reactive oxygen species and cell signaling: Respiratory burst in macrophage signaling. Am J Respir Crit Care Med 2002 166 S4-S8
123. Shapiro BM. The control of oxidant stress at fertilization. Science 1991 252 533-536
124. Swezey RR, Epel D. Enzyme stimulation upon fertilization is revealed in electrically permeabilized sea urchin eggs. Proc Natl Acad Sci U S A 1988 85 812-816
125. Spencer NY, Yan Z, Boudreau RL, Zhang Y, Luo M, Li Q, et al. Control of hepatic nuclear superoxide production by glucose 6-phosphate dehydrogenase and NADPH oxidase-4. J Biol Chem 2011 286 8977-8987
126. Gupte RS, Floyd BC, Kozicky M, George S, Ungvari ZI, Neito V, et al. Synergistic activation of glucose-6-phosphate dehydrogenase and NAD(P)H oxidase by Src kinase elevates superoxide in type 2 diabetic, Zucker fa/fa, rat liver. Free Radic Biol Med 2009; 47: 219-228
127. Lin CJ, Ho HY, Cheng ML, You TH, Yu JS, Chiu DT. Impaired dephosphorylation renders G6PD-knockdown HepG2 cells more susceptible to H(2)O(2)-induced apoptosis. Free Radic Biol Med 2010; 49: 361-373
128. Lin HR, Wu CC, Wu YH, Hsu CW, Cheng ML, Chiu DT. Proteome-wide dysregulation by glucose-6-phosphate dehydrogenase (G6PD) reveals a novel protective role for G6PD in afl atoxin B 1 -mediated cytotoxicity. J Proteome Res 2013 12 3434-3448
129. Hu T, Zhang C, Tang Q, Su Y, Li B, Chen L, et al. Variant G6PD levels promote tumor cell proliferation or apoptosis via the STAT3/5 pathway in the human melanoma xenograft mouse model. BMC Cancer 2013 13 251
130. Ho HY, Cheng ML, Shiao MS, Chiu DT. Characterization of global metabolic responses of glucose-6-phosphate dehydrogenase-defi cient hepatoma cells to diamide-induced oxidative stress. Free Radic Biol Med 2013; 54: 71-84
131. Yeh GC, Daschner PJ, Lopaczynska J, MacDonald CJ, Ciolino HP. Modulation of glucose-6-phosphate dehydrogenase activity and expression is associated with aryl hydrocarbon resistance in vitro. J Biol Chem 2001 276 34708-34713
132. Wagle A, Jivraj S, Garlock GL, Stapleton SR. Insulin regulation of glucose-6-phosphate dehydrogenase gene expression is rapamycin-sensitive and requires phosphatidylinositol 3-kinase. J Biol Chem 1998 273 14968-14974
133. Katsurada A, Iritani N, Fukuda H, Matsumura Y, Noguchi T, Tanaka T. Eff ects of nutrients and insulin on transcriptional and post-Transcriptional regulation of glucose-6-phosphate dehydrogenase synthesis in rat liver. Biochim Biophys Acta 1989 1006 104-110
134. Amir-Ahmady B, Salati LM. Regulation of the processing of glucose-6-phosphate dehydrogenase mRNA by nutritional status. J Biol Chem 2001 276 10514-10523
135. Tao H, Szeszel-Fedorowicz W, Amir-Ahmady B, Gibson MA, Stabile LP, Salati LM. Inhibition of the splicing of glucose-6-phosphate dehydrogenase precursor mRNA by polyunsaturated fatty acids. J Biol Chem 2002 277 31270-31278
136. Szeszel-Fedorowicz W, Talukdar I, Griffi th BN, Walsh CM, Salati LM. An exonic splicing silencer is involved in the regulated splicing of glucose 6-phosphate dehydrogenase mRNA. J Biol Chem 2006; 281: 34146-34158
137. Walsh CM, Suchanek AL, Cyphert TJ, Kohan AB, Szeszel-Fedorowicz W, Salati LM. Serine arginine splicing factor 3 is involved in enhanced splicing of glucose-6-phosphate dehydrogenase RNA in response to nutrients and hormones in liver. J Biol Chem 2013 288 2816-2828
138. Donohue TM Jr, Barker KL. Glucose-6-phosphate dehydrogenase. Translational regulation of synthesis and regulation of processing of the enzyme in the uterus by estradiol. Biochim Biophys Acta 1983 739 148-157
139. Stanton RC, Seifter JL, Boxer DC, Zimmerman E, Cantley LC. Rapid release of bound glucose-6-phosphate dehydrogenase by growth factors. Correlation with increased enzymatic activity. J Biol Chem 1991 266 12442-12448
140. Tian WN, Pignatare JN, Stanton RC. Signal transduction proteins that associate with the platelet-derived growth factor (PDGF) receptor mediate the PDGF-induced release of glucose-6-phosphate dehydrogenase from permeabilized cells. J Biol Chem 1994 269 14798-14805
141. Pan S, World CJ, Kovacs CJ, Berk BC. Glucose 6-phosphate dehydrogenase is regulated through c-Src-mediated tyrosine phosphorylation in endothelial cells. Arterioscler Thromb Vasc Biol 2009 29 895-901
142. Bensaad K, Tsuruta A, Selak MA, Vidal MN, Nakano K, Bartrons R, et al. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 2006; 126: 107-120
143. Du W, Jiang P, Mancuso A, Stonestrom A, Brewer MD, Minn AJ, et al. TAp73 enhances the pentose phosphate pathway and supports cell proliferation. Nat Cell Biol 2013 15 991-1000
144. Cosentino C, Grieco D, Costanzo V. ATM activates the pentose phosphate pathway promoting anti-oxidant defence and DNA repair. EMBO J 2011 30 546-555
145. Costa Rosa LF, Curi R, Murphy C, Newsholme P. Eff ect of adrenaline and phorbol myristate acetate or bacterial lipopolysaccharide on stimulation of pathways of macrophage glucose, glutamine and O2 metabolism. Evidence for cyclic AMPdependent protein kinase mediated inhibition of glucose-6-phosphate dehydrogenase and activation of NADP- -dependent ' malic' enzyme. Biochem J 1995; 310: 709-714
146. Xu Y, Osborne BW, Stanton RC. Diabetes causes inhibition of glucose-6-phosphate dehydrogenase via activation of PKA, which contributes to oxidative stress in rat kidney cortex. Am J Physiol Renal Physiol 2005 289 F1040-F1047
147. Zhang Z, Apse K, Pang J, Stanton RC. High glucose inhibits glucose-6-phosphate dehydrogenase via cAMP in aortic endothelial cells. J Biol Chem 2000 275 40042-40047
148. Talukdar I, Szeszel-Fedorowicz W, Salati LM. Arachidonic acid inhibits the insulin induction of glucose-6-phosphate dehydrogenase via p38 MAP kinase. J Biol Chem 2005 280 40660-40667
149. Kohan AB, Talukdar I, Walsh CM, Salati LM. A role for AMPK in the inhibition of glucose-6-phosphate dehydrogenase by polyunsaturated fatty acids. Biochem Biophys Res Commun 2009 388 117-121
150. Jiang P, Du W, Wang X, Mancuso A, Gao X, Wu M, Yang X. p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase. Nat Cell Biol 2011 13 310-316
151. Cai J, Chen Y, Seth S, Furukawa S, Compans RW, Jones DP. Inhibition of infl uenza infection by glutathione. Free Radic Biol Med 2003 34 928-936
152. Beck MA. The infl uence of antioxidant nutrients on viral infection. Nutr Rev 1998 56 S140-S146
153. Beck MA, Levander OA, Handy J. Selenium defi ciency and viral infection. J Nutr 2003 133 1463S-7S
154. Beck MA, Kolbeck PC, Rohr LH, Shi Q, Morris VC, Levander OA. Benign human enterovirus becomes virulent in selenium-defi cient mice. J Med Virol 1994 43 166-170
155. Beck MA, Kolbeck PC, Rohr LH, Shi Q, Morris VC, Levander OA. Vitamin E defi ciency intensifi es the myocardial injury of coxsackievirus B3 infection of mice. J Nutr 1994 124 345-358
156. Ho HY, Cheng ML, Weng SF, Chang L, Yeh TT, Shih SR, Chiu DT. Glucose-6-phosphate dehydrogenase defi ciency enhances enterovirus 71 infection. J Gen Virol 2008 89 2080-2089
157. Wu YH, Tseng CP, Cheng ML, Ho HY, Shih SR, Chiu DT. Glucose-6-phosphate dehydrogenase defi ciency enhances human coronavirus 229E infection. J Infect Dis 2008 197 812-816
158. Ho HY, Cheng ML, Weng SF, Leu YL, Chiu DT. Antiviral eff ect of epigallocatechin gallate on enterovirus 71. J Agric Food Chem 2009; 57: 6140-6147
159. Chao YC, Huang CS, Lee CN, Chang SY, King CC, Kao CL. Higher infection of dengue virus serotype 2 in human monocytes of patients with G6PD defi ciency. PLoS One 2008 3 e1557
160. Hsieh YT, Lin MH, Ho HY, Chen LC, Chen CC, Shu JC. Glucose-6-phosphate dehydrogenase (G6PD)-defi cient epithelial cells are less tolerant to infection by Staphylococcus aureus. PLoS One 2013; 8: E79566
161. Wilmanski J, Villanueva E, Deitch EA, Spolarics Z. Glucose-6-phosphate dehydrogenase defi ciency and the infl ammatory response to endotoxin and polymicrobial sepsis. Crit Care Med 2007 35 510-518
162. Ozolins TR, Siksay DL, Wells PG. Modulation of embryonic glutathione peroxidase activity and phenytoin teratogenicity by dietary deprivation of selenium in CD-1 mice. J Pharmacol Exp Ther 1996 277 945-953
163. Wells PG, Kim PM, Laposa RR, Nicol CJ, Parman T, Winn LM. Oxidative damage in chemical teratogenesis. Mutat Res 1997 396 65-78
164. Wells PG, Winn LM. Biochemical toxicology of chemical teratogenesis. Crit Rev Biochem Mol Biol 1996 31 1-40
165. Winn LM, Wells PG. Evidence for embryonic prostaglandin H synthase-catalyzed bioactivation and reactive oxygen species-mediated oxidation of cellular macromolecules in phenytoin and benzo[a]pyrene teratogenesis. Free Radic Biol Med 1997 22 607-621
166. Nicol CJ, Zielenski J, Tsui LC, Wells PG. An embryoprotective role for glucose-6-phosphate dehydrogenase in Developmental oxidative stress and chemical teratogenesis. FASEB J 2000; 14: 111-127
167. Filosa S, Fico A, Paglialunga F, Balestrieri M, Crooke A, Verde P, et al. Failure to increase glucose consumption through the pentose-phosphate pathway results in the death of glucose-6-phosphate dehydrogenase gene-deleted mouse embryonic stem cells subjected to oxidative stress. Biochem J 2003 370 935-943
168. Fico A, Paglialunga F, Cigliano L, Abrescia P, Verde P, Martini G, et al. Glucose-6-phosphate dehydrogenase plays a crucial role in protection from redox-stress-induced apoptosis. Cell Death Diff er 2004 11 823-831
169. Paglialunga F, Fico A, Iaccarino I, Notaro R, Luzzatto L, Martini G, Filosa S. G6PD is indispensable for erythropoiesis after the embryonic-Adult hemoglobin switch. Blood 2004 104 3148-3152
170. Pretsch W, Charles DJ, Merkle S. X-linked glucose-6-phosphate dehydrogenase defi ciency in Mus musculus. Biochem Genet 1988 26 89-103
171. Perez-Crespo M, Ramirez MA, Fernandez-Gonzalez R, Rizos D, Lonergan P, Pintado B, Gutierrez-Adan A. Diff erential sensitivity of male and female mouse embryos to oxidative induced heat-stress is mediated by glucose-6-phosphate dehydrogenase gene expression. Mol Reprod Dev 2005 72 502-510
172. Manganelli G, Fico A, Masullo U, Pizzolongo F, Cimmino A, Filosa S. Modulation of the pentose phosphate pathway induces endodermal diff erentiation in embryonic stem cells. PLoS One 2012 7 e29321
173. Yang HC, Chen TL, Wu YH, Cheng KP, Lin YH, Cheng ML, et al. Glucose 6-phosphate dehydrogenase defi -ciency enhances germ cell apoptosis and causes defective embryogenesis in Caenorhabditis elegans. Cell Death Dis 2013 4 e616
174. Patrinostro X, Carter ML, Kramer AC, Lund TC. A model of glucose-6-phosphate dehydrogenase defi ciency in the zebrafi sh. Exp Hematol 2013 41 697-710. e2
175. Manganelli G, Masullo U, Passarelli S, Filosa S. Glucose-6-phosphate dehydrogenase defi ciency: Disadvantages and possible benefi ts. Cardiovasc Hematol Disord Drug Targets 2013 13 73-82
176. Tsai KJ, Hung IJ, Chow CK, Stern A, Chao SS, Chiu DT. Impaired production of nitric oxide, superoxide, and hydrogen peroxide in glucose 6-phosphate-dehydrogenasedefi cient granulocytes. FEBS Lett 1998 436 411-414
177. Leopold JA, Cap A, Scribner AW, Stanton RC, Loscalzo J. Glucose-6-phosphate dehydrogenase defi ciency promotes endothelial oxidant stress and decreases endothelial nitric oxide bioavailability. FASEB J 2001 15 1771-1773
178. Zhang Z, Yang Z, Zhu B, Hu J, Liew CW, Zhang Y, et al. Increasing glucose 6-phosphate dehydrogenase activity restores redox balance in vascular endothelial cells exposed to high glucose. PLoS One 2012; 7: E49128
179. Jain M, Brenner DA, Cui L, Lim CC, Wang B, Pimentel DR, et al. Glucose-6-phosphate dehydrogenase modulates cytosolic redox status and contractile phenotype in adult cardiomyocytes. Circ Res 2003; 93: E9-e16
180. Rawat DK, Hecker P, Watanabe M, Chettimada S, Levy RJ, Okada T, et al. Glucose-6-phosphate dehydrogenase and NADPH redox regulates cardiac myocyte L-Type calcium channel activity and myocardial contractile function. PLoS One 2012 7 e45365
181. Jain M, Cui L, Brenner DA, Wang B, Handy DE, Leopold JA, et al. Increased myocardial dysfunction after ischemiareperfusion in mice lacking glucose-6-phosphate dehydrogenase . Circulation 2004 109 898-903
182. Hecker PA, Lionetti V, Ribeiro RF Jr, Rastogi S, Brown BH, O 'Connell KA, et al. Glucose 6-phosphate dehydrogenase defi ciency increases redox stress and moderately accelerates the development of heart failure. Circ Heart Fail 2013 6 118-126
183. Hecker PA, Leopold JA, Gupte SA, Recchia FA, Stanley WC. Impact of glucose-6-phosphate dehydrogenase defi ciency on the pathophysiology of cardiovascular disease. Am J Physiol Heart Circ Physiol 2013 304 H491-H500
184. Matsui R, Xu S, Maitland KA, Mastroianni R, Leopold JA, Handy DE, et al. Glucose-6-phosphate dehydrogenase defi -ciency decreases vascular superoxide and atherosclerotic lesions in apolipoprotein E(- /- ) mice. Arterioscler Thromb Vasc Biol 2006 26 910-916
185. Gupte SA, Kaminski PM, Floyd B, Agarwal R, Ali N, Ahmad M, et al. Cytosolic NADPH may regulate diff erences in basal Nox oxidase-derived superoxide generation in bovine coronary and pulmonary arteries. Am J Physiol Heart Circ Physiol 2005 288 H13-H21
186. Serpillon S, Floyd BC, Gupte RS, George S, Kozicky M, Neito V, et al. Superoxide production by NAD(P)H oxidase and mitochondria is increased in genetically obese and hyperglycemic rat heart and aorta before the development of cardiac dysfunction. The role of glucose-6-phosphate dehydrogenase-derived NADPH. Am J Physiol Heart Circ Physiol 2009 297 H153-H162
187. Kato T, Niizuma S, Inuzuka Y, Kawashima T, Okuda J, Tamaki Y, et al. Analysis of metabolic remodeling in compensated left ventricular hypertrophy and heart failure. Circ Heart Fail 2010 3 420-430
188. Gupte RS, Vijay V, Marks B, Levine RJ, Sabbah HN, Wolin MS, et al. Upregulation of glucose-6-phosphate dehydrogenase and NAD(P)H oxidase activity increases oxidative stress in failing human heart. J Card Fail 2007; 13: 497-506
189. Assad RS, Atik FA, Oliveira FS, Fonseca-Alaniz MH, Abduch MC, Silva GJ, et al. Reversible pulmonary trunk banding. VI: Glucose-6-phosphate dehydrogenase activity in rapid ventricular hypertrophy in young goats. J Thorac Cardiovasc Surg 2011 142:1108-1113, 1113 e1
190. Gupte SA. Glucose-6-phosphate dehydrogenase: A novel therapeutic target in cardiovascular diseases. Curr Opin Investig Drugs 2008 9 993-1000
191. Zimmer HG. The oxidative pentose phosphate pathway in the heart: Regulation, physiological signifi cance, and clinical implications. Basic Res Cardiol 1992; 87: 303-316
192. Zimmer HG. Regulation of and intervention into the oxidative pentose phosphate pathway and adenine nucleotide metabolism in the heart. Mol Cell Biochem 1996 160-161 101-109
193. Wolin MS, Ahmad M, Gupte SA. Oxidant and redox signaling in vascular oxygen sensing mechanisms: Basic concepts, current controversies, and potential importance of cytosolic NADPH. Am J Physiol Lung Cell Mol Physiol 2005 289 L159-L173
194. Brewer AC, Mustafi SB, Murray TV, Rajasekaran NS, Benjamin IJ. Reductive stress linked to small HSPs, G6PD, and Nrf2 pathways in heart disease. Antioxid Redox Signal 2013 18 1114-1127
195. Matsui R, Xu S, Maitland KA, Hayes A, Leopold JA, Handy DE, et al. Glucose-6 phosphate dehydrogenase defi ciency decreases the vascular response to angiotensin II. Circulation 2005; 112: 257-263
196. Gaskin RS, Estwick D, Peddi R. G6PD defi ciency: Its role in the high prevalence of hypertension and diabetes mellitus. Ethn Dis 2001 11 749-754
197. Diaz-Flores M, Ibanez-Hernandez MA, Galvan RE, Gutierrez M, Duran-Reyes G, Medina-Navarro R, et al. Glucose-6-phosphate dehydrogenase activity and NADPH/ NADP ratio in liver and pancreas are dependent on the severity of hyperglycemia in rat. Life Sci 2006; 78: 2601-2607
198. Katare R, Caporali A, Emanueli C, Madeddu P. Benfotiamine improves functional recovery of the infarcted heart via activation of pro-survival G6PD/Akt signaling pathway and modulation of neurohormonal response. J Mol Cell Cardiol 2010 49 625-638
199. Zhang Z, Liew CW, Handy DE, Zhang Y, Leopold JA, Hu J, et al. High glucose inhibits glucose-6-phosphate dehydrogenase, leading to increased oxidative stress and beta-cell apoptosis. FASEB J 2010 24 1497-1505
200. Niazi GA. Glucose-6-phosphate dehydrogenase defi ciency and diabetes mellitus. Int J Hematol 1991 54 295-298
201. Wan GH, Tsai SC, Chiu DT. Decreased blood activity of glucose-6-phosphate dehydrogenase associates with increased risk for diabetes mellitus. Endocrine 2002 19 191-195
202. Carette C, Dubois-Laforgue D, Gautier JF, Timsit J. Diabetes mellitus and glucose-6-phosphate dehydrogenase defi ciency: From one crisis to another. Diabetes Metab 2011 37 79-82
203. Heymann AD, Cohen Y, Chodick G. Glucose-6-phosphate dehydrogenase defi ciency and type 2 diabetes. Diabetes Care 2012 35 e58
204. Cappai G, Songini M, Doria A, Cavallerano JD, Lorenzi M. Increased prevalence of proliferative retinopathy in patients with type 1 diabetes who are defi cient in glucose-6-phosphate dehydrogenase. Diabetologia 2011; 54: 1539-1542
205. Park J, Rho HK, Kim KH, Choe SS, Lee YS, Kim JB. Overexpression of glucose-6-phosphate dehydrogenase is associated with lipid dysregulation and insulin resistance in obesity. Mol Cell Biol 2005 25 5146-5157
206. Mailloux RJ, Harper ME. Glucose regulates enzymatic sources of mitochondrial NADPH in skeletal muscle cells; a novel role for glucose-6-phosphate dehydrogenase. FASEB J 2010 24 2495-2506
207. Schaff er WT. Eff ects of growth hormone on lipogenic enzyme activities in cultured rat hepatocytes. Am J Physiol 1985 248 E719-E725
208. Sun Y. Free radicals, antioxidant enzymes, and carcinogenesis. Free Radic Biol Med 1990; 8: 583-599
209. Sulis E. G.-6-P.D. defi ciency and cancer. Lancet 1972 299 1185
210. Bezwoda WR, Derman DP, See N, Mansoor N. Relative value of oestrogen receptor assay, lactoferrin content, and glucose-6-phosphate dehydrogenase activity as prognostic indicators in primary breast cancer. Oncology 1985; 42: 7-12
211. Kuo W, Lin J, Tang TK. Human glucose-6-phosphate dehydrogenase (G6PD) gene transforms NIH 3T3 cells and induces tumors in nude mice. Int J Cancer 2000 85 857-864
212. Forteleoni G, Argiolas L, Farris A, Ferraris AM, Gaetani GF, Meloni T. G6PD defi ciency and breast cancer. Tumori 1988 74 665-667
213. Pisano M, Cocco P, Cherchi R, Onnis R, Cherchi P. Glucose-6-phosphate dehydrogenase defi ciency and lung cancer: A hospital based case-control study. Tumori 1991 77 12-15
214. Cocco P, Todde P, Fornera S, Manca MB, Manca P, Sias AR. Mortality in a cohort of men expressing the glucose-6-phosphate dehydrogenase defi ciency. Blood 1998 91 706-709
215. Cheng AJ, Chiu DT, See LC, Liao CT, Chen IH, Chang JT. Poor prognosis in nasopharyngeal cancer patients with low glucose-6-phosphate-dehydrogenase activity. Jpn J Cancer Res 2001 92 576-581
216. Zhang C, Zhang Z, Zhu Y, Qin S. Glucose-6-phosphate dehydrogenase: A biomarker and potential therapeutic target for cancer. Anticancer Agents Med Chem 2014 14 280-289
217. Hui L, Hong Y, Jingjing Z, Yuan H, Qi C, Nong Z. HGF suppresses high glucose-mediated oxidative stress in mesangial cells by activation of PKG and inhibition of PKA. Free Radic Biol Med 2010; 49: 467-473
218. Xu Y, Zhang Z, Hu J, Stillman IE, Leopold JA, Handy DE, et al. Glucose-6-phosphate dehydrogenase-defi cient mice have increased renal oxidative stress and increased albuminuria . FASEB J 2010 24 609-616
219. Assaf AA, Tabbara KF, el-Hazmi MA. Cataracts in glucose-6-phosphate dehydrogenase defi ciency. Ophthalmic Paediatr Genet 1993 14 81-86
220. Balaji M, Sasikala K, Sundararajulu G, Ravindran T, Sathar ML. Analysis of glucose-6-phosphate dehydrogenase in anterior subcapsular and mixed cataractous lenses. Br J Ophthalmol 1995 79 1124-1125
221. Wan GH, Lin KK, Tsai SC, Chiu DT. Decreased glucose-6-phosphate- dehydrogenase (G6PD) activity and risk of senile cataract in Taiwan. Ophthalmic Epidemiol 2006 13 109-114
222. Peiretti E, Mandas A, Cocco P, Norfo C, Abete C, Angius F, et al. Glucose-6-phosphate-dehydrogenase defi ciency as a risk factor for pterygium. Invest Ophthalmol Vis Sci 2010 51 2928-2935
223. Ho HY, Cheng ML, Wang YH, Chiu DT. Flow cytometry for assessment of the effi cacy of siRNA. Cytometry A 2006 69 1054-1061
224. Lant B, Derry WB. Methods for detection and analysis of apoptosis signaling in the C. elegans germline. Methods 2013 61 174-182
225. Kamath RS, Fraser AG, Dong Y, Poulin G, Durbin R, Gotta M, et al. Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. Nature 2003 421 231-237. CMRPD1A0521, CMRPD1A0522, CMRPD391683, CMRPD1C0441 and CMRPD1C0761^CGU^Chang Gung University